Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Bank Multiarta Sentosa Tbk. (MASB) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Bank Multiarta Sentosa Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Bank Multiarta Sentosa Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Bank Multiarta Sentosa Tbk. trades at Rp3,390 (market cap 4.7T, 10.8K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 96.7K 24h volume). The key difference: Bank Multiarta Sentosa Tbk. is far larger — about 28.1× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (96.7K versus 10.8K). Which is the better fit depends on your goals.

MASBOBAT
Market Cap
4.7T167.37B
Volume
10.8K96.7K
Lot
108967
Turnover
36.52M23.82M
Average Price
3,381.85246.34
Value
36.52M23.82M
Indicative Equilibrium Price
248
Indicative Equilibrium Volume
41

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

MASB
View details
OBAT
View details

About Bank Multiarta Sentosa Tbk.

PT Bank Multiarta Sentosa Tbk (the Bank) was established by Deed No.201 dated July 28, 1992 of H.Saidus Sjahar, S.H. The Bank's parent company is PT Danabina Sentana which is the majority stockholder of the Bank. The majority shareholder of PT Danabina Sentana is PT Lumbung Artakencana which is a company established in Indonesia and the Bank’s ultimate shareholder that joined in business group of Wings Group.

Read more on MASB

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT